Postherpetic Neuralgia

Postherpetic neuralgia (PHN) is a chronic neuropathic pain syndrome defined as pain persisting more than 3 months after the resolution of herpes zoster-associated rash. It is often characterized as spontaneous aching or burning with paroxysmal shooting pains in the affected dermatome and may be accompanied by allodynia or hyperalgesia. There is an increased incidence of PHN in elderly patients, patients with ophthalmic herpes zoster, and immunocompromised patients. PHN may result from dorsal horn destruction, although pathophysiologic changes in more proximal central structures and distal peripheral structures have been described. Based on randomized, controlled studies, the most effective medical therapies include gabapentin, topical lidocaine, tricyclic antidepressants, and oral opioid analgesics. Surgical interventions for refractory cases including intrathecal drug administration, central ablative procedures, and central electrical stimulation continue to meet with limited success.

KEYWORDS

Postherpetic neuralgia - pain - varicella-zoster

REFERENCES

• 1 Dworkin R H, Portenoy R K. Proposed classification of herpes zoster pain.  Lancet. 1994;  343 1648
• 2 Ragozzino M W, Melton L J, Kurkland L T. Population based study of herpes zoster and its sequelae.  Medicine (Baltimore). 1982;  61 310-316
• 3 Stankus S J, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia.  Am Fam Physician. 2000;  61 2437-2444
• 4 Donahue J G, Choo P W, Manson J E, Platt R. The incidence of herpes zoster.  Arch Intern Med. 1995;  155 1605-1609
• 5 Smith J B, Fenske N A. Herpes zoster and internal malignancy.  South Med J. 1995;  88 1089-1092
• 6 Juel-Jensen B E, MacCallum F O. Herpes Simplex, Varicella, and Zoster: Clinical Manifestations and Treatment. Philadelphia; Lippincott 1972
• 7 De Moragas J M, Kierland R R. The outcome of patients with herpes zoster.  Arch Dermatol. 1957;  75 193-196
• 8 Choo P W, Galil K, Donahue J G, Walker A M, Spiegelman D, Platt R. Risk factors for postherpetic neuralgia.  Arch Intern Med. 1997;  157 1217-1224
• 9 White J C, Sweet W H. Pain and the Neurosurgeon: A Forty-Year Experience. Springfield, IL; Charles C Thomas 1969: 380-382 472-477
• 10 Smith F P. Pathological studies of spinal nerve ganglia in relation to intractable intercostal pain.  Surg Neurol. 1978;  10 50-53
• 11 Watson C P, Deck J H. The neuropathology of herpes zoster with particular reference to postherpetic neuralgia and its pathogenesis. In: Watson CP Herpes Zoster and Postherpetic Neuralgia. Amsterdam; Elsevier 1993: 139-158
• 12 Zacks S I, Langfitt T W, Elliott F A. Herpetic neuritis. A light and electron microscopic study.  Neurology. 1964;  14 744-750
• 13 Noordenbos W. Problems pertaining to the transmission of nerve impulses which give rise to pain: preliminary statement. Pain. Amsterdam; Elsevier 1959: 6-10
• 14 Lourie H, King R B. Sensory and neurohistological correlates of cutaneous hyperpathia.  Arch Neurol. 1966;  14 313-320
• 15 Weddell G, Sinclair D C, Feindel W H. An anatomical basis for alterations in quality of pain sensibility.  J Neurophysiol. 1948;  11 99-109
• 16 Woolf C J, Shortland P, Coggewhall R E. Peripheral nerve injury triggers central sprouting of myelinated afferents.  Nature. 1992;  355 75-78
• 17 Johnson R. Herpes zoster: predicting and minimizing the impact of post-herpetic neuralgia.  J Antimicrob Chemother. 2001;  47(suppl T1) 1-8
• 18 Wood M J, Kay R, Dworkin R H, Soong S J, Whitley R J. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials.  Clin Infect Dis. 1996;  22 341-347
• 19 Beutner K R, Friedman D J, Forszpaniak C, Andersen P L, Wood M J. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.  Antimicrob Agents Chemother. 1995;  39 1546-1553
• 20 Tyring S, Barbarash R A, Nahlik J E et al.. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial.  Ann Intern Med. 1995;  123 89-96
• 21 Dworkin R H, Boon R J, Griffin D R, Phung D. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients.  J Infect Dis. 1998;  178(suppl 1) S76-S80
• 22 Huff J C, Drucker J L, Clemmer A et al.. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis.  J Med Virol. 1993;  (suppl 1) 93-96
• 23 Whitley R J, Weiss H, Gnann J, Tyring S, Mertz G J, Pappas P G. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.  Ann Intern Med. 1996;  125 376-383
• 24 Esmann V, Geil J P, Kroon S, Fogh H, Pereslund N A, Petersen C S. Prednisone does not prevent post-herpetic neuralgia.  Lancet. 1987;  2 126-129
• 25 Hugler P, Siebrecht P, Hoffmann K et al.. Prevention of postherpetic neuralgia with varicella-zoster hyperimmune globulin.  Eur J Pain. 2002;  6 435-445
• 26 Watson C P, Watt V R, Chipman M, Birkett N, Evans R J. The prognosis with postherpetic neuralgia.  Pain. 1991;  46 195-199
• 27 Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial.  J Pain Symptom Manage. 1997;  13 327-331
• 28 Ardid D, Guilbaud G. Antinociceptive effects of acute and chronic injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats.  Pain. 1992;  49 279-287
• 29 Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.  JAMA. 1998;  280 1837-1842
• 30 Gerson G R, Jones R B, Luscombe D K. Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia.  Postgrad Med J. 1977;  53(suppl 4) 104-109
• 31 Filadora V A, Sist T C, Lema M J. Acute herpetic neuralgia and postherpetic neuralgia in the head and neck: response to gabapentin in five cases.  Reg Anesth Pain Med. 1999;  24 170-174
• 32 Rice A SC, Maton S. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study. Postherpetic Neuralgia Study Group.  Pain. 2001;  94 215-224
• 33 Moshe S L. Mechanisms of action of anticonvulsant agents.  Neurology. 2000;  55(suppl 1) S32-S40
• 34 Ross E L. The evolving role of antiepileptic drugs in treating neuropathic pain.  Neurology. 2000;  55(suppl 1) S41-S46
• 35 Rowbotham M C, Davies P S, Verdempinck C et al.. Lidocaine patch: double-blind controlled study of a new treatment method for postherpetic neuralgia.  Pain. 1996;  65 39-44
• 36 Galer B S, Rowbotham M C, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.  Pain. 1999;  80 533-538
• 37 Rowbotham M C, Reisner-Keller L A, Fields H L. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia.  Neurology. 1991;  41 1024-1028
• 38 Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.  Neurology. 1998;  50 1837-1841
• 39 Raja S N, Haythornthwaite J A, Pappagallo M et al.. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial.  Neurology. 2002;  59 1015-1021
• 40 Wood M J, Johnson R W, McKendrick M W, Taylor J, Mandal B K, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.  N Engl J Med. 1994;  330 896-900
• 41 Whitley R J, Weiss H, Gnann J W et al.. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial.  Ann Intern Med. 1996;  125 376-383
• 42 Schmader K E, Studenski S. Are current therapies useful for the prevention of postherpetic neuralgia? A critical analysis of the literature.  J Gen Intern Med. 1989;  4 83-89
• 43 Kotani N, Kushikata T, Hashimoto H et al.. Intrathecal methylprednisolone for intractable postherpetic neuralgia.  N Engl J Med. 2000;  343 1514-1519
• 44 Lampe J B, Hindinger C, Reichmann H. Intrathecal methylprednisolone for postherpetic neuralgia.  N Engl J Med. 2001;  344 1019-1022
• 45 King R B. Concerning the management of pain associated with herpes zoster and postherpetic neuralgia.  Pain. 1988;  33 73-78
• 46 Abadir A R, Kraynack B J, Mayda J, Gintautas J. Postherpetic neuralgia: response to topical clonidine.  Proc West Pharmacol Soc. 1996;  39 47-48
• 47 Tajti J, Somogyi I, Szilard J. Treatment of chronic pain syndromes with transcutaneous iontophoresis of vinca alkaloids, with special regard to post-herpetic neuralgia.  Acta Med Hung. 1989;  46 3-12
• 48 Young R F. Clinical experience with radiofrequency and laser DREZ lesions.  J Neurosurg. 1990;  72 715-720
• 49 Meglio M, Cioni B, Rossi G F. Spinal cord stimulation in the management of chronic pain. A 9 year experience.  J Neurosurg. 1989;  70 519-524
• 50 Friedman A H, Bullitt E. Dorsal root entry zone lesions in the treatment of pain following brachial plexus avulsion, spinal cord injury and herpes zoster.  Appl Neurophysiol. 1988;  51 164-169
• 51 Husain A M, Elliott S L, Gorecki J P. Neurophysiological monitoring for the nucleus caudalis dorsal root entry zone operation.  Neurosurgery. 2002;  50 822-827
• 52 Gorecki J P, Nashold Jr B S, Rubin L, Ovelmen-Levitt J. The Duke experience with nucleus caudalis dorsal root entry zone operation.  Stereotact Funct Neurosurg. 1995;  65 111-116